-
Bad medicine: the toxic fakes at the heart of an international criminal racket
The recent news that another batch of fake meningitis vaccine had been discovered in Niger is just the most recent incidence of a particularly dangerous and cruel criminal racket. As many as 1,500 cases have been reported to a surveillance database launched by the World Health Organization in 2013, and that’s probably an underestimate, says Mick Deats, head of the substandard and falsified medicines group at WHO.
- Categories
- Health Care
-
India grants Pfizer patent on pneumonia vaccine in blow to aid group
The decision by India's patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India until 2026. It's a big victory for the U.S. drugmaker in a market that has the world's largest number of pneumonia cases, a lung disease that kills nearly a million children a year globally.
- Categories
- Health Care
- Region
- South Asia
-
Experimental HIV vaccine regimen is well-tolerated, elicits immune responses
Results from an early-stage clinical trial called APPROACH show that an investigational HIV vaccine regimen was well-tolerated and generated immune responses against HIV in healthy adults.
- Categories
- Health Care
- Tags
- healthcare, HIV/AIDS, vaccines
-
Opinion: How technology is helping India move toward smart service delivery
In 2015, India launched eVIN, or electronic vaccine intelligence network — a smart, easy-to-use technology aimed at digitizing vaccine stocks in the country. It’s no small ask in a nation with the largest and most ambitious immunization program in the world — aiming to immunize some 156 million women and children each year.
- Categories
- Health Care, Technology
- Region
- South Asia
-
Dissolvable patch offers radical pain-free alternative to flu injection, study finds
“I think this product would greatly simplify access to vaccines and perhaps improve coverage as well,” said Nadine Rouphael, a co-author of the research and associate professor of medicine at Emory University School of Medicine.
- Categories
- Health Care
-
Q&A: Rajeev Venkayya on why vaccines are a worthy investment
Venkayya has seen vaccines from every angle. Before launching Takeda’s global vaccine business five years ago, he served as senior director for biodefense at the White House and director of global health delivery at the Bill & Melinda Gates Foundation. The success of vaccines going forward, he says, requires public and policy support for investments “to make sure that we're driving strong immunization coverage everywhere but also investing in new vaccines for the diseases that should be vaccine preventable,” he said.
- Categories
- Health Care
-
Solar power: A shot in the arm for India’s health centers
Nearly 35 million people in rural India relied on un-electrified primary health centers as of 2015, according to government data. One in every two primary health centers has no electricity or suffers from power outages, putting baby deliveries, paediatric emergencies and cold storage of vaccines at risk, among other vital health services. Renewable energy sources like solar power provide an opportunity to work around the challenges that accompany a lack of electricity.
- Categories
- Energy, Health Care
- Region
- South Asia
- Tags
- health care, India, renewable energy, vaccines
-
Asean to buy vaccines in bulk
The Philippines and nine other countries of the Association of Southeast Asian Nations are looking at the possibility of buying in bulk to address the issue on supply inadequacy of affordable vaccines in the region.
- Categories
- Health Care
- Region
- South Asia
Parent Organization
